172 related articles for article (PubMed ID: 21192086)
1. MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis.
Jacobin-Valat MJ; Deramchia K; Mornet S; Hagemeyer CE; Bonetto S; Robert R; Biran M; Massot P; Miraux S; Sanchez S; Bouzier-Sore AK; Franconi JM; Duguet E; Clofent-Sanchez G
NMR Biomed; 2011 May; 24(4):413-24. PubMed ID: 21192086
[TBL] [Abstract][Full Text] [Related]
2. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice.
Hamilton JR; Cornelissen I; Mountford JK; Coughlin SR
Atherosclerosis; 2009 Aug; 205(2):427-32. PubMed ID: 19217621
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
6. Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR
Przyborowski K; Kassassir H; Wojewoda M; Kmiecik K; Sitek B; Siewiera K; Zakrzewska A; Rudolf AM; Kostogrys R; Watala C; Zoladz JA; Chlopicki S
Platelets; 2017 Nov; 28(7):657-667. PubMed ID: 28067100
[TBL] [Abstract][Full Text] [Related]
7. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
8. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
[TBL] [Abstract][Full Text] [Related]
9. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
[TBL] [Abstract][Full Text] [Related]
10. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
[TBL] [Abstract][Full Text] [Related]
11. P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.
Théorêt JF; Bienvenu JG; Kumar A; Merhi Y
J Pharmacol Exp Ther; 2001 Aug; 298(2):658-64. PubMed ID: 11454928
[TBL] [Abstract][Full Text] [Related]
12. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
13. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations.
Leytin V; Mody M; Semple JW; Garvey B; Freedman J
Biochem Biophys Res Commun; 2000 Mar; 269(1):85-90. PubMed ID: 10694482
[TBL] [Abstract][Full Text] [Related]
15. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
16. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
[TBL] [Abstract][Full Text] [Related]
19. [Iron-oxide-enhanced MR imaging of inflammatory atherosclerotic lesions: overview of experimental and initial clinical results].
Schmitz SA
Rofo; 2003 Apr; 175(4):469-76. PubMed ID: 12677500
[TBL] [Abstract][Full Text] [Related]
20. An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber.
von Elverfeldt D; Meissner M; Peter K; Paul D; Meixner F; Neudorfer I; Merkle A; Harloff A; Zirlik A; Schöllhorn J; Markl M; Hennig J; Bode C; von zur Muhlen C
Contrast Media Mol Imaging; 2012; 7(2):204-13. PubMed ID: 22434633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]